Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check4 days agoChange DetectedThe study record history now shows a new release entry, Revision: v3.6.4, replacing the prior Revision: v3.6.3. This is a non-content update to the page's revision history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe record history now includes the new release revision v3.6.3, replacing the previous v3.6.2. This reflects a software update to the ClinicalTrials.gov interface rather than changes to study data.SummaryDifference0.1%

- Check33 days agoChange DetectedRecord History now shows a new revision entry for v3.6.2, replacing the previous v3.6.0 in the version list.SummaryDifference0.1%

- Check47 days agoChange DetectedRecruitment status updated to no longer looking for participants. The history now includes a new revision entry (v3.6.0) to document this update.SummaryDifference0.4%

- Check54 days agoChange DetectedThe history now includes a new entry for Revision: v3.5.5, and the previous Revision: v3.5.4 entry has been removed, reflecting a small platform update to the record history display.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag moved from v3.5.3 to v3.5.4, indicating a new version of the record history. This reflects an update to the page's metadata rather than changes to the underlying study data.SummaryDifference0.1%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.